163 related articles for article (PubMed ID: 29251621)
21. [The significance of dynamic detection of WT1 expression on patients of hematologic malignancy following allogeneic hematopoietic stem cell transplantation].
Jin S; Liu DH; Xu LP; Chen H; Chen YH; Qin YZ; Liu YR; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):578-81. PubMed ID: 19035171
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.
Bornhäuser M; Oelschlaegel U; Platzbecker U; Bug G; Lutterbeck K; Kiehl MG; Schetelig J; Kiani A; Illmer T; Schaich M; Theuser C; Mohr B; Brendel C; Fauser AA; Klein S; Martin H; Ehninger G; Thiede C
Haematologica; 2009 Nov; 94(11):1613-7. PubMed ID: 19880783
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
Malagola M; Polverelli N; Beghin A; Bolda F; Comini M; Farina M; Morello E; Radici V; Accorsi Buttini E; Bernardi S; Re F; Leoni A; Bonometti D; Brugnoni D; Lanfranchi A; Russo D
Front Oncol; 2023; 13():1133418. PubMed ID: 36950550
[TBL] [Abstract][Full Text] [Related]
26. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
[TBL] [Abstract][Full Text] [Related]
27. Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.
Terwey TH; Hemmati PG; Nagy M; Pfeifer H; Gökbuget N; Brüggemann M; Le Duc TM; le Coutre P; Dörken B; Arnold R
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1522-9. PubMed ID: 24907626
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome.
Lee JM; Kim YJ; Park SS; Han E; Kim M; Kim Y
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31795155
[TBL] [Abstract][Full Text] [Related]
29. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.
Taira C; Matsuda K; Yamaguchi A; Uehara M; Sugano M; Okumura N; Honda T
Clin Chim Acta; 2015 May; 445():101-6. PubMed ID: 25797898
[TBL] [Abstract][Full Text] [Related]
30. Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.
Liacini A; Tripathi G; McCollick A; Gravante C; Abdelmessieh P; Shestovska Y; Mathew L; Geier S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511573
[TBL] [Abstract][Full Text] [Related]
31. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.
Ahci M; Stempelmann K; Buttkereit U; Crivello P; Trilling M; Heinold A; Steckel NK; Koldehoff M; Horn PA; Beelen DW; Fleischhauer K
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1658-1668. PubMed ID: 28603070
[TBL] [Abstract][Full Text] [Related]
32. Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism.
Woehlecke C; Wittig S; Sanft J; Kreyenberg H; Gruhn B
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1283-90. PubMed ID: 25617314
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
Román J; Alvarez MA; Torres A
Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
[TBL] [Abstract][Full Text] [Related]
34. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
[TBL] [Abstract][Full Text] [Related]
35. [Significance of Monitoring Minimal Residual Disease by Flow Cytometry in Acute Leukemia Patients Underwent Nonmyeloablative Allo-HSCT].
Liu XX; Liu TQ; Guo M; Sun QY; Qiao JH; Hu KX; Li BX; Yao B; Yu CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):873-879. PubMed ID: 28641652
[TBL] [Abstract][Full Text] [Related]
36. [Detection of bcr/abl fusion gene changes in patients with chronic myeloid leukemia after allo-HSCT by real-time quantitative reverse transcription polymerase chain reaction and its significance].
Xue M; Wang HX; Duan LN; Yan HM; Zhu L; Liu J; Ding L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1350-3. PubMed ID: 19099642
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
[TBL] [Abstract][Full Text] [Related]
38. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
Kwon M; Martínez-Laperche C; Infante M; Carretero F; Balsalobre P; Serrano D; Gayoso J; Pérez-Corral A; Anguita J; Díez-Martín JL; Buño I
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1235-42. PubMed ID: 22281301
[TBL] [Abstract][Full Text] [Related]
40. Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML.
Duléry R; Nibourel O; Gauthier J; Elsermans V; Behal H; Coiteux V; Magro L; Renneville A; Marceau A; Boyer T; Quesnel B; Preudhomme C; Duhamel A; Yakoub-Agha I
Bone Marrow Transplant; 2017 Apr; 52(4):539-543. PubMed ID: 28067876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
